96 related articles for article (PubMed ID: 8721099)
1. [Basic studies on the 111In labeled antisense oligonucleotide for tumor imaging].
Fujibayashi Y; Nakagawa K; Waki A; Sakahara H; Konishi J; Yokoyama A
Kaku Igaku; 1996 Feb; 33(2):115-22. PubMed ID: 8721099
[TBL] [Abstract][Full Text] [Related]
2. A novel 111In-labeled antisense DNA probe with multi-chelating sites (MCS-probe) showing high specific radioactivity and labeling efficiency.
Fujibayashi Y; Yoshimi E; Waki A; Sakahara H; Saga T; Konishi J; Yonekura Y; Yokoyama A
Nucl Med Biol; 1999 Jan; 26(1):17-21. PubMed ID: 10096496
[TBL] [Abstract][Full Text] [Related]
3. In vitro detection of mdr1 mRNA in murine leukemia cells with 111In-labeled oligonucleotide.
Bai J; Yokoyama K; Kinuya S; Shiba K; Matsushita R; Nomura M; Michigishi T; Tonami N
Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1523-9. PubMed ID: 15449049
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model.
Dewanjee MK; Ghafouripour AK; Kapadvanjwala M; Dewanjee S; Serafini AN; Lopez DM; Sfakianakis GN
J Nucl Med; 1994 Jun; 35(6):1054-63. PubMed ID: 8195870
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy using antisense oligodeoxynucleotides labeled with Auger-emitting radionuclides.
Kairemo KJ; Tenhunen M; Jekunen AP
Cancer Gene Ther; 1998; 5(6):408-12. PubMed ID: 9917096
[TBL] [Abstract][Full Text] [Related]
6. In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
Cancer Res; 2000 Sep; 60(17):4804-11. PubMed ID: 10987290
[TBL] [Abstract][Full Text] [Related]
7. Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors.
Orlova A; Tran T; Widström C; Engfeldt T; Eriksson Karlström A; Tolmachev V
Int J Mol Med; 2007 Sep; 20(3):397-404. PubMed ID: 17671747
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts.
Fu P; Shen B; Zhao C; Tian G
J Nucl Med; 2010 Nov; 51(11):1805-12. PubMed ID: 20956468
[TBL] [Abstract][Full Text] [Related]
9. Uptake kinetics of 99mTc-MAG3-antisense oligonucleotide to PCNA and effect on gene expression in vascular smooth muscle cells.
Zhang YR; Zhang YX; Cao W; Lan XL
J Nucl Med; 2005 Jun; 46(6):1052-8. PubMed ID: 15937319
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
11. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-labeled N-myc antisense oligonucleotides.
Watanabe N; Sawai H; Ogihara-Umeda I; Tanada S; Kim EE; Yonekura Y; Sasaki Y
J Nucl Med; 2006 Oct; 47(10):1670-7. PubMed ID: 17015904
[TBL] [Abstract][Full Text] [Related]
12. 68Ga-labeled oligonucleotides for in vivo imaging with PET.
Roivainen A; Tolvanen T; Salomäki S; Lendvai G; Velikyan I; Numminen P; Välilä M; Sipilä H; Bergström M; Härkönen P; Lönnberg H; Långström B
J Nucl Med; 2004 Feb; 45(2):347-55. PubMed ID: 14960659
[TBL] [Abstract][Full Text] [Related]
13. Scintigraphic detection of overexpressed c-erbB-2 protooncogene products by a class-switched murine anti-c-erbB-2 protein monoclonal antibody.
Saga T; Endo K; Akiyama T; Sakahara H; Koizumi M; Watanabe Y; Nakai T; Hosono M; Yamamoto T; Toyoshima K
Cancer Res; 1991 Feb; 51(3):990-4. PubMed ID: 1671001
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
[TBL] [Abstract][Full Text] [Related]
15. alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
Yoshimoto M; Ogawa K; Washiyama K; Shikano N; Mori H; Amano R; Kawai K
Int J Cancer; 2008 Aug; 123(3):709-15. PubMed ID: 18498129
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a fluorine-18 labeled antisense oligonucleotide as a potential PET tracer for iNOS mRNA expression.
de Vries EF; Vroegh J; Dijkstra G; Moshage H; Elsinga PH; Jansen PL; Vaalburg W
Nucl Med Biol; 2004 Jul; 31(5):605-12. PubMed ID: 15219279
[TBL] [Abstract][Full Text] [Related]
17. Early detection of chemoresistance in vivo through the use of a radiolabeled antisense oligonucleotide.
Touboul M; Gauchez AS; D'Hardemare Adu M; Lunardi J; Deverre JR; Pernin C; Mathieu JP; Vuillez JP; Fagret D
Anticancer Res; 2002; 22(6A):3349-56. PubMed ID: 12530086
[TBL] [Abstract][Full Text] [Related]
18. Preparation and Evaluation of (99m)Tc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors.
Zhao X; Wang N; Ren X; Zhang J; Wang J; Han J; Jia L; Liu Y; Zhang Z
J Nucl Med; 2014 Jun; 55(6):1008-16. PubMed ID: 24744447
[TBL] [Abstract][Full Text] [Related]
19. Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology.
Suzuki T; Wu D; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
J Nucl Med; 2004 Oct; 45(10):1766-75. PubMed ID: 15471847
[TBL] [Abstract][Full Text] [Related]
20. Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice.
Sato N; Kobayashi H; Saga T; Nakamoto Y; Ishimori T; Togashi K; Fujibayashi Y; Konishi J; Brechbiel MW
Clin Cancer Res; 2001 Nov; 7(11):3606-12. PubMed ID: 11705883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
